Xiao-Jun Huang Selected Research

Hematologic Neoplasms (Hematological Malignancy)

1/2022	CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCT.
11/2021	Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies.
11/2021	Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.
6/2021	Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
1/2021	Graft Failure in Patients With Hematological Malignancies: A Successful Salvage With a Second Transplantation From a Different Haploidentical Donor.
1/2021	Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation.
10/2020	Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.
10/2020	Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation.
1/2020	Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies.
1/2020	Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Jun Huang Research Topics

Disease

90	Leukemia 10/2022 - 10/2005
79	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 09/2001
54	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 02/2005
47	Residual Neoplasm 10/2022 - 07/2008
43	Infections 01/2022 - 09/2001
37	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 06/2004
33	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2007
26	Neoplasms (Cancer) 01/2022 - 04/2007
22	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 11/2007
21	Thrombocytopenia (Thrombopenia) 01/2022 - 04/2009
20	Aplastic Anemia (Anemia, Hypoplastic) 12/2022 - 04/2004
16	Hematologic Diseases (Blood Diseases) 01/2022 - 08/2009
15	Bronchiolitis Obliterans Syndrome 01/2022 - 04/2007
15	Philadelphia Chromosome 11/2021 - 02/2005
13	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 05/2016
13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2008
13	Multiple Myeloma 08/2020 - 03/2007
10	Hemorrhage 01/2022 - 01/2007
10	Acute Promyelocytic Leukemia 01/2021 - 07/2009
10	Hypoxia (Hypoxemia) 01/2018 - 04/2007
6	Viremia 06/2021 - 01/2007
5	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2007
5	Pneumonia (Pneumonitis) 10/2021 - 06/2009
5	Hemorrhagic Cystitis 07/2018 - 01/2007
5	Fever (Fevers) 08/2016 - 04/2007
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 10/2011
4	Hepatitis B 01/2022 - 07/2004
4	Disease Progression 01/2021 - 02/2012
4	Wilms Tumor (Wilm's Tumor) 11/2019 - 04/2010
3	Virus Diseases (Viral Diseases) 11/2022 - 01/2014
3	Thrombotic Microangiopathies 01/2022 - 02/2018
3	Demyelinating Diseases (Demyelinating Disease) 11/2021 - 03/2013
3	Testicular Neoplasms (Testicular Cancer) 01/2021 - 02/2014
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020 - 12/2007
3	Familial paroxysmal dystonia 01/2020 - 01/2018
3	Melanoma (Melanoma, Malignant) 11/2019 - 05/2010
3	Lymphoma (Lymphomas) 10/2019 - 10/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 05/2016
3	Neutropenia 10/2015 - 01/2009

Drug/Important Bio-Agent (IBA)

25	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 04/2007
21	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 04/2004
16	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 02/2005
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
11	Inosine Triphosphate (ITP)IBA 01/2022 - 05/2016
10	AntigensIBA 01/2022 - 05/2010
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 03/2007
9	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 08/2013
9	InterferonsIBA 01/2022 - 11/2015
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2011
8	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2020 - 12/2012
7	SteroidsIBA 01/2022 - 12/2018
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2011
7	ArsenicIBA 01/2018 - 08/2013
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2005
6	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 11/2013
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2020 - 07/2008
6	Messenger RNA (mRNA)IBA 08/2020 - 10/2008
6	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 05/2008
5	Biological ProductsIBA 11/2022 - 05/2011
5	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2006
5	Prostaglandins FIBA 01/2022 - 10/2015
5	Immunoglobulin G (IgG)IBA 11/2021 - 07/2012
5	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 07/2008
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2020 - 08/2008
5	LigandsIBA 12/2019 - 04/2007
4	CytokinesIBA 01/2022 - 08/2010
4	Basiliximab FDA Link 01/2022 - 01/2020
4	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 06/2009
4	AntibodiesIBA 11/2020 - 01/2008
4	Bortezomib (Velcade)FDA Link 03/2018 - 10/2011
4	rhodiolosideIBA 01/2017 - 08/2013
3	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2006
3	Thrombopoietin (c-mpl Ligand)IBA 01/2022 - 03/2010
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 10/2011
3	human PRRT2 proteinIBA 01/2020 - 12/2014
3	NucleophosminIBA 01/2020 - 02/2009
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
3	Busulfan (Busulfex)FDA Link 01/2018 - 03/2007
3	realgar-indigo naturalisIBA 01/2018 - 11/2013
3	nilotinib FDA Link 01/2017 - 02/2012
3	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2016 - 06/2013
3	Hemoglobins (Hemoglobin)IBA 10/2015 - 04/2007
3	EnzymesIBA 12/2009 - 09/2001
2	erucylphosphocholineIBA 10/2022 - 01/2018

Therapy/Procedure

179	Hematopoietic Stem Cell Transplantation 12/2022 - 01/2007
88	Transplantation 12/2022 - 04/2004
60	Therapeutics 01/2022 - 10/2005
54	Stem Cell Transplantation 03/2022 - 07/2004
31	Drug Therapy (Chemotherapy) 10/2022 - 04/2007
16	Haploidentical Transplantation 01/2021 - 04/2007
11	Cell Transplantation 01/2020 - 04/2006
8	Immunotherapy 05/2021 - 01/2013
5	Aftercare (After-Treatment) 01/2021 - 05/2011
5	Donor Selection 01/2021 - 04/2016
5	Induction Chemotherapy 01/2021 - 11/2013
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2017 - 02/2009
3	Salvage Therapy 01/2021 - 10/2016
3	Consolidation Chemotherapy 03/2019 - 01/2016